These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22771946)

  • 1. p53 and metabolism: old player in a new game.
    Sen N; Satija YK; Das S
    Transcription; 2012; 3(3):119-23. PubMed ID: 22771946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
    Schaefer T; Steiner R; Lengerke C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The positive regulation of p53 by the tumor suppressor VHL.
    Roe JS; Youn HD
    Cell Cycle; 2006 Sep; 5(18):2054-6. PubMed ID: 16969113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor p53 and its mutants in cancer metabolism.
    Liu J; Zhang C; Hu W; Feng Z
    Cancer Lett; 2015 Jan; 356(2 Pt A):197-203. PubMed ID: 24374014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect.
    Johnson RF; Perkins ND
    Trends Biochem Sci; 2012 Aug; 37(8):317-24. PubMed ID: 22626470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
    Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
    Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ezerskyte M; Paredes JA; Malvezzi S; Burns JA; Margison GP; Olsson M; Scicchitano DA; Dreij K
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4731-4736. PubMed ID: 29666243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugging in the absence of p53.
    Aning OA; Cheok CF
    J Mol Cell Biol; 2019 Mar; 11(3):255-264. PubMed ID: 30865230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.
    Marzi I; Cipolleschi MG; D'Amico M; Stivarou T; Rovida E; Vinci MC; Pandolfi S; Dello Sbarba P; Stecca B; Olivotto M
    Cell Cycle; 2013 Jan; 12(2):353-64. PubMed ID: 23287475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
    Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
    Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational research? Ribosome integrity and a new p53 tumor suppressor checkpoint.
    Opferman JT; Zambetti GP
    Cell Death Differ; 2006 Jun; 13(6):898-901. PubMed ID: 16557265
    [No Abstract]   [Full Text] [Related]  

  • 14. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Punish or cherish: p53, metabolism and tumor suppression].
    Albagli O
    Med Sci (Paris); 2015 Oct; 31(10):869-80. PubMed ID: 26481026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53: a two-faced cancer gene.
    Kastan MB; Berkovich E
    Nat Cell Biol; 2007 May; 9(5):489-91. PubMed ID: 17473858
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 18. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
    Fifield BA; Qemo I; Kirou E; Cardiff RD; Porter LA
    Breast Cancer Res; 2019 Dec; 21(1):140. PubMed ID: 31829284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.